Ascend Performance Materials to Present Vydyne® Electrically Neutral Grades at Performance Polyamides Conference in Cologne
Ascend Performance Materials, the largest fully integrated producer of PA66 resin, will be presenting on heat-stabilized and electrically-neutral nylon 6,6 compounds at the 2017 Performance Polyamides conference.
The presentation, titled “Heat-stable and electrically-neutral PA66 compounds for sensors and connectors used in harsh environments”, will focus on Ascend’s Vydyne ® J Series . Vydyne J Series compounds are electrically neutral, heat-stabilized, and offer enhanced flow for the molding of thin wall parts and improved productivity, as well as high dielectric strength and dimensional stability for miniaturized applications such as connectors and other intricate components.
“In working with automotive parts and electrical and electronic component manufacturers, we have developed a number of nylon 6,6 solutions for use in harsh environments,” said Jeff Fritsch, Ascend’s business development manager for Europe. “Vydyne products deliver superior hydrolysis, chemical and heat resistance, and are used in numerous sensors and connector applications. The unique properties of our nylon 6,6 resins and compounds are helping the automotive industry adapt to new technologies and global trends.”
Ascend’s presentation will be given on June 7, 2017, at the Maritim Hotel in Cologne, Germany.
About Ascend Performance Materials
Ascend Performance Materials is a global premium provider of high-quality plastics, fibers and chemicals. Ascend is one of the world’s largest integrated PA66 producers, with its own in-house manufacturing facilities, ensuring total security of supply. Ascend’s product range has earned it an unequalled reputation for quality, innovative techniques and an enlightened approach to business that expands the horizons of possibility. With eight global locations and more than 2,400 people working at our sites around the world, Ascend has the inspiration, the expertise, the people and the attitude toward innovation to consistently deliver the right solution for customers.
Together, we’re making a difference.
Together, we’re inspiring everyday.
More information about Ascend can be found at www.ascendmaterials.com
About SK Capital
SK Capital is a private investment firm with a disciplined focus on the specialty materials, chemicals and healthcare sectors. The firm’s purpose is to build strong and growing businesses that create substantial long-term economic value. SK utilizes its industry, operating and investment experience to identify opportunities to transform businesses into higher performing organizations with improved strategic positioning, growth and profitability as well as lower operating risk. SK Capital’s portfolio companies generate revenues of approximately $8 billion annually and employ approximately 9,000 people. The firm currently manages more than $1.5 billion of committed capital. For more information, please visit www.skcapitalpartners.com
Although the information and recommendations set forth herein (hereinafter “Information”) are presented in good faith and believed to be correct as of the date hereof, Ascend Performance Materials Operations LLC makes no representations or warranties as to the completeness or accuracy thereof. The full disclaimer of warranty and liability can be found at ascendmaterials.com/disclaimer.
©2017 Ascend Performance Materials Operations LLC. The Ascend Performance Materials and Vydyne marks and logos are trademarks or registered trademarks of Ascend Performance Materials Operations LLC.
Ascend Performance Materials
Osama Khalifa, +1 832-963-1347
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
CELLTRION15.12.2017 23:15 | pressemeddelelse
Celltrion Receives Positive CHMP Opinion for Herzuma® for Trastuzumab Biosimilar
TAKEDA15.12.2017 13:36 | pressemeddelelse
Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease
TWISPAY15.12.2017 13:23 | pressemeddelelse
Bitcoin Romania and Twispay Announce Integration Partnership Providing Users with the Ability to Purchase Bitcoin with Bank Cards
PEACE-FORUM15.12.2017 12:40 | pressemeddelelse
Upon Conclusion of the Fourth Annual Forum for Promoting Peace in Muslim Societies, Scholars and Intellectuals Visit the Louvre Abu Dhabi Museum
CA-KENNEDY-WILSON15.12.2017 12:02 | pressemeddelelse
Kennedy Wilson Acquires 124-Unit Northbank Apartments in Dublin, Ireland for €45 Million
NV-NAC-FOUNDATION15.12.2017 10:02 | pressemeddelelse
AML BitCoin Enters Phase II of ICO
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum